Skip to content

Patterns of Adult Food Allergy (PAFA-Stage 2)

Patterns and prevalence of adult food allergy in a UK population (PAFA-Stage 2)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN12016140
Enrollment
1500
Registered
2022-03-14
Start date
2021-12-01
Completion date
Unknown
Last updated
2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult food allergy Not Applicable

Interventions

PAFA-Stage 2 follows on from PAFA-Stage 1 community survey where people in the general population aged 18-70 years living in Manchester, Southampton or the Isle of Wight were asked if they experienced

Sponsors

Manchester University NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. All must be respondents to the PAFA-Stage 1 community survey and consent to be invited to take part in PAFA-Stage 2 2. Cases will be identified as participants who responded to the PAFA-Stage 1 and indicated they have a self-reported adverse reaction to food which is consistent with it being a possible food allergy 3. Controls will be identified as participants who responded to the PAFA-Stage 1 and indicated they do not have a self-reported adverse reaction to food 4. Both cases and controls will be capable of giving informed consent

Exclusion criteria

Exclusion criteria: Adults who have dementia, Alzheimer’s disease, or are receiving palliative care

Design outcomes

Primary

MeasureTime frame
Probable IgE-mediated food allergy, which is defined as all of: 1. Self-reported symptoms associated with consumption of a particular food which are typical of an IgE-mediated food allergy (see list below) [administered questionnaire] 2. Symptoms onset within 2 hours of contact with food [administered questionnaire] 3. Evidence of sensitization to the same food in the form of a positive skin prick test (SPT; =3 mm wheal) and/or positive serum specific IgE (=0.35 kU/L) and/or positive serum specific IgE to component associated with clinical allergy (=0.35 kU/L) to the same food. Symptoms considered to be typical of IgE-mediated food allergy include any of the following: itching or tingling in the mouth, lips, ears or throat; swelling of the eyes, lips, or mouth; nettle sting like rash or itchy skin, or red rash; diarrhoea (other than food poisoning); vomiting (other than food poisoning); stomach cramps; hoarseness or swelling of throat; a runny, stuffy nose, or sneezing; red, sore, or running eyes; cough, wheeze, chest tightness, or breathlessness; fainting or dizziness. Timepoint: December 2022

Secondary

MeasureTime frame
Probable non-IgE mediated adverse reaction to food, which is defined as all of: 1. Self-reported symptoms associated with consumption of a particular food which are typical of a non-IgE-mediated adverse reaction to food (see below) [administered questionnaire] 2. Symptoms after 2 hours of consumption [administered questionnaire] 3. No evidence of sensitisation to food in the form of a negative skin prick test (SPT; <3 mm wheal) and/or negative serum specific IgE (<0.35 kU/L) to the same food. Symptoms typical of non-IgE mediated adverse reaction to food include any of the following: difficulty swallowing; regurgitating stomach contents (stomach contents raising back to the oesophagus or mouth); reflux/ heartburn/indigestion; fainting or dizziness; headaches; stomach cramps; diarrhoea (other than food poisoning); vomiting (other than food poisoning); constipation; other digestive problems (e.g. bloating, wind) Timepoint: December 2022

Countries

Netherlands, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026